TSL.L Regulatory News (TSL)

14 Mar 2008 14:21

Highland & Universal Securities Ltd14 March 2008 The Rule 8.3- Tissue Science announcement released today at 11.15 under RNS No 1127Q has been amended. Amendments are identified with an asterisk (*). The full amended text is shown below. FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) HIGHLAND & UNIVERSAL SECURITIES LTD Company dealt in TISSUE SCIENCE LABORATORIES PLC Class of relevant security to which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 12 MARCH 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total * NONE (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total * NONE (c) Rights to subscribe (Note 3) Class of relevant security: Details * NONE 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 577,242 ORDINARY SHARES 101 1/2 PENCE (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) * NONE (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying * NONE Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) * N/A (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) * N/A (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) * NONE 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 14 MARCH 2008 Contact name A.J. MACFIE Telephone number 0777 1508 901 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange